Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Inform ; 38(8-9): e1800127, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-30730112

RESUMO

Quantitative structure-toxicity relationship (QSTR) models were built for two in vitro endpoints: cytotoxicity and enzymatic activity of diverse chemicals to goldfish (Crassius auratus) scale tissue (GFS) and topminnow (Poeciliopsis lucida) hepatoma cell line (PLHC-1), respectively. The data sets were based on experimental cytotoxicity measured with uptake of 3-amino-7-dimethylamino-2-methylphenazine hydrochloride dye (Neutral Red assay) representing lysosomal damage and enzymatic activity measured with Ethoxyresorufin-O-deethylase (EROD) induction potency. The descriptors were calculated with DRAGON 6 and SPARTAN 10 software packages. Descriptor selection was made by 'All Subset' and Genetic Algorithm-based features implemented in QSARINS software. The proposed QSTR models validated both internally and externally. Additionally, the QSTR models generated for cytotoxicity and EROD induction potency were used to predict the relevant endpoint values for external set chemicals with structural coverage of 95.0 % and 92.1 %, respectively. A strong correlation of experimental in vivo fish lethality data with predicted in vitro cytotoxicity and EROD induction potency values for external set chemicals was found. It was concluded that the proposed QSTR models might be useful to provide an initial screening and prioritization for these diverse chemicals. Also, regarding the strong correlations between predicted in vitro and experimental in vivo data, the use of QSTR predictions as an alternative to the acute fish toxicity assessment can be claimed.


Assuntos
Antineoplásicos/farmacologia , Carcinoma Hepatocelular/tratamento farmacológico , Inibidores Enzimáticos/farmacologia , Neoplasias Hepáticas/tratamento farmacológico , Relação Quantitativa Estrutura-Atividade , Animais , Antineoplásicos/química , Carcinoma Hepatocelular/patologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Citocromo P-450 CYP1A1/antagonistas & inibidores , Citocromo P-450 CYP1A1/metabolismo , Inibidores Enzimáticos/química , Fundulidae , Carpa Dourada , Neoplasias Hepáticas/patologia , Vermelho Neutro/química , Vermelho Neutro/farmacologia , Fenazinas/química , Fenazinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...